111 related articles for article (PubMed ID: 29443173)
1. Is nonadmission-based care for TIA patients cost-effective?: A microcosting study.
Sanders LM; Cadilhac DA; Srikanth VK; Chong CP; Phan TG
Neurol Clin Pract; 2015 Feb; 5(1):58-66. PubMed ID: 29443173
[TBL] [Abstract][Full Text] [Related]
2. Monash transient ischemic attack triaging treatment: safety of a transient ischemic attack mechanism-based outpatient model of care.
Sanders LM; Srikanth VK; Jolley DJ; Sundararajan V; Psihogios H; Wong K; Ramsay D; Phan TG
Stroke; 2012 Nov; 43(11):2936-41. PubMed ID: 22984016
[TBL] [Abstract][Full Text] [Related]
3. Changes in acute hospital costs after employing clinical facilitators to improve stroke care in Victoria, Australia.
Cadilhac DA; Dewey HM; Denisenko S; Bladin CF; Meretoja A
BMC Health Serv Res; 2019 Jan; 19(1):41. PubMed ID: 30658645
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of Australia's Active After-School Communities program.
Moodie ML; Carter RC; Swinburn BA; Haby MM
Obesity (Silver Spring); 2010 Aug; 18(8):1585-92. PubMed ID: 19893504
[TBL] [Abstract][Full Text] [Related]
5. The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting.
Morgan RB; McCullagh L; Barry M; Daly C
Ir J Med Sci; 2017 May; 186(2):293-303. PubMed ID: 27864782
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
Tan Tanny SP; Busija L; Liew D; Teo S; Davis SM; Yan B
Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
[TBL] [Abstract][Full Text] [Related]
7. Do burn patients cost more? The intensive care unit costs of burn patients compared with controls matched for length of stay and acuity.
Patil V; Dulhunty JM; Udy A; Thomas P; Kucharski G; Lipman J
J Burn Care Res; 2010; 31(4):598-602. PubMed ID: 20489652
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole.
Chambers M; Hutton J; Gladman J
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):577-93. PubMed ID: 10662482
[TBL] [Abstract][Full Text] [Related]
10. Should TIA patients be hospitalized or referred to a same-day clinic?: a decision analysis.
Joshi JK; Ouyang B; Prabhakaran S
Neurology; 2011 Dec; 77(24):2082-8. PubMed ID: 22094477
[TBL] [Abstract][Full Text] [Related]
11. Organized blood pressure control programs to prevent stroke in Australia: would they be cost-effective?
Cadilhac DA; Carter R; Thrift AG; Dewey HM
Stroke; 2012 May; 43(5):1370-5. PubMed ID: 22363058
[TBL] [Abstract][Full Text] [Related]
12. What difference a decade? The costs of psychosis in Australia in 2000 and 2010: comparative results from the first and second Australian national surveys of psychosis.
Neil AL; Carr VJ; Mihalopoulos C; Mackinnon A; Lewin TJ; Morgan VA
Aust N Z J Psychiatry; 2014 Mar; 48(3):237-48. PubMed ID: 24220136
[TBL] [Abstract][Full Text] [Related]
13. The Costs of Confronting Osteoporosis: Cost Study of an Australian Fracture Liaison Service.
Major G; Ling R; Searles A; Niddrie F; Kelly A; Holliday E; Attia J; Bogduk N
JBMR Plus; 2019 Jan; 3(1):56-63. PubMed ID: 30680364
[TBL] [Abstract][Full Text] [Related]
14. Medical health care utilization cost of patients presenting with psychogenic nonepileptic seizures.
Seneviratne U; Low ZM; Low ZX; Hehir A; Paramaswaran S; Foong M; Ma H; Phan TG
Epilepsia; 2019 Feb; 60(2):349-357. PubMed ID: 30577087
[TBL] [Abstract][Full Text] [Related]
15. Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting.
Epifanov Y; Dodel R; Haacke C; Schaeg M; Schöffski O; Hennerici M; Back T
Health Policy; 2007 May; 81(2-3):339-49. PubMed ID: 16930763
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Shanahan MD; Doran CM; Digiusto E; Bell J; Lintzeris N; White J; Ali R; Saunders JB; Mattick RP; Gilmour S
Addict Behav; 2006 Mar; 31(3):371-87. PubMed ID: 15972245
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of cognitive behavioral therapy for bulimia nervosa in the Australian context.
Le LK; Hay P; Wade T; Touyz S; Mihalopoulos C
Int J Eat Disord; 2017 Dec; 50(12):1367-1377. PubMed ID: 29044626
[TBL] [Abstract][Full Text] [Related]
18. The modeled cost-effectiveness of family-based and adolescent-focused treatment for anorexia nervosa.
Le LK; Barendregt JJ; Hay P; Sawyer SM; Hughes EK; Mihalopoulos C
Int J Eat Disord; 2017 Dec; 50(12):1356-1366. PubMed ID: 29044637
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
